Azitra (AZTR) Interest Expenses (2022 - 2026)
Azitra (AZTR) reported Interest Expenses of $3411.0 for Q1 2026, up 163.81% on a YoY basis from $1293.0 in Q1 2025, and down 37.46% quarter-over-quarter from $5454.0 in Q4 2025.
Azitra (AZTR) Interest Expenses (2022 - 2026) Analysis & Trends
Azitra has reported Interest Expenses for 5 years, with the latest figure at $3411.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest Expenses rose 163.81% year-over-year to $3411.0; the trailing twelve-month figure through Mar 2026 stood at $9705.0 (down 22.6% YoY), and the FY2025 full-year result was $7587.0, down 37.61% from the prior year.
- Interest Expenses for Q1 2026 stood at $3411.0, down from $5454.0 in the prior quarter.
- The five-year high for Interest Expenses was $185110.0 in Q4 2022, with the low at $372.0 in Q3 2025.
- Historically, Interest Expenses has averaged $26339.4 across 5 years, with a median of $3631.0 in 2024.
- Annual changes were most pronounced in 2023 — Interest Expenses sank 99.46% — and 2024, when it jumped 462.89%.
- Azitra's Interest Expenses stood at $185110.0 in 2022, then slumped by 99.46% to $997.0 in 2023, then jumped by 462.89% to $5612.0 in 2024, then slipped by 2.82% to $5454.0 in 2025, then tumbled by 37.46% to $3411.0 in 2026.
- The last three Interest Expenses figures came in at $3411.0 (Q1 2026), $5454.0 (Q4 2025), and $372.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -332,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 61,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -5.58 Mn |
| 10 | Azitra | 20,900.00 | 20,900.00 | - | 3,411.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,411.00 |
| Mar 31, 2026 | 3,411.00 |
| Dec 31, 2025 | 5,454.00 |
| Dec 31, 2025 | 5,454.00 |
| Sep 30, 2025 | 372.00 |
| Sep 30, 2025 | 372.00 |
| Jun 30, 2025 | 468.00 |
| Jun 30, 2025 | 468.00 |
| Mar 31, 2025 | 1,293.00 |
| Mar 31, 2025 | 1,293.00 |
| Dec 31, 2024 | 5,612.00 |
| Dec 31, 2024 | 5,612.00 |
| Sep 30, 2024 | 3,851.00 |
| Sep 30, 2024 | 3,851.00 |
| Jun 30, 2024 | 1,782.00 |
| Jun 30, 2024 | 1,782.00 |
| Mar 31, 2024 | 915.00 |
| Mar 31, 2024 | 915.00 |
| Dec 31, 2023 | 997.00 |
| Dec 31, 2023 | 997.00 |